What is Eloxx Pharmaceuticals, Inc. (ELOX) stock price today?

Eloxx Pharmaceuticals, Inc. (ELOX) is currently trading at $13.74, down 9.49% today.

What is ELOX P/E ratio?

Eloxx Pharmaceuticals, Inc.'s P/E ratio is -9.79. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is ELOX return on equity (ROE)?

Eloxx Pharmaceuticals, Inc.'s return on equity (ROE) is -42.52%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Eloxx Pharmaceuticals, Inc.'s market cap?

Eloxx Pharmaceuticals, Inc. has a market capitalization of $47.21M.

— · Biotechnology

Eloxx Pharmaceuticals, Inc. (ELOX) Stock

$13.74 -9.49% —: ELOX Healthcare

Valuation

Metric	Value
Price	$13.74
Market Cap	$47.21M
P/E Ratio	-9.79
P/B Ratio	2.18
P/S Ratio	0.00
EPS (TTM)	$-5.39
52-Week High	$23.40
52-Week Low	$8.20
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-42.52%
ROA	-13.02%
ROCE	-17.76%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	-0.08
Current Ratio	0.29

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	—	—	$0
Operating Profit	$-42.0M	$-34.0M	—	—	$-6.0M
Net Profit	$-67.0M	$-36.0M	—	—	$-6.0M
EPS	$-419.65	$-183.15	—	—	$-5.39
Op Margin	—	—	—	—	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$45.0M	$21.0M	$2.0M	$3.0M	$5.0M
Total Liabilities	$23.0M	$32.0M	$24.0M	$27.0M	$17.0M
Cash	$43.0M	$19.0M	$1.0M	$0	$5.0M
Borrowings	$13.0M	$13.0M	$4.0M	$7.0M	$1.0M

Latest News

Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq PR Newswire · Jun 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-35.0M	$-32.0M	$-14.0M	$-5.0M	$-6.0M
Investing Cash Flow	$2.0M	$0	$0	$0	$6.0M
Financing Cash Flow	$3.0M	$9.0M	$0	$0	$9.0M
Net Cash Flow	$18.0M	$-23.0M	$-18.0M	$-1.0M	$-15.0M
Free Cash Flow	$-35.0M	$-32.0M	$-14.0M	$-5.0M	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.11
EV / EBITDA	1.32
FCF Yield	-20.03%
Quick Ratio	3.74
Interest Coverage	-222.84
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held26.28%

Institutions Held40.88%

Institutions Float Held55.46%

Institutional Holder	Shares	Report Date
Activest Wealth Management	4	2026-06-30

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BIOCQBiocept, Inc.	$0.00	—	-0.01	$525	0.00%
CDXICardax, Inc.	$0.00	—	0.00	$80	0.00%
HTGMQHTG Molecular Diagnostics, Inc.	$0.00	—	0.00	$221	0.00%
MDVLQMedAvail Holdings, Inc.	$0.00	—	-0.05	$161	0.00%
MICRDMicron Solutions, Inc.	$0.00	—	0.00	$317	0.00%

About Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc. (ELOX) stock trades at $13.74 with a market capitalization of $47.21M. The stock is valued at a price-to-earnings (P/E) ratio of -9.79, price-to-book of 2.18, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $8.20 and $23.40, and currently trades 41.3% below its 52-week high.

On profitability, Eloxx Pharmaceuticals, Inc. generates a return on equity (ROE) of -42.52%, return on capital employed of -17.76%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides